Amarantus Bioscience Holdings Inc (AMBS)

[tsuguy]

I don't expect any large cash infusion until after the LymPro spinoff. I think once that is done we will hear about how that division will be monetized and money will flow into holding company. It has been mentioned several times that it is the intent of AMBS to have such a structure for its' pipeline to transition, so for them to not establish LymPro spinoff into stand alone diagnostic division first seems unrealistic. This also gives them an opportunity to redirect more shares for management. I